Evidence map›Paper›PMID 40632188›Full record

ArticleBiotechnology letters2025

High throughput screening and metabolic engineering of Saccharopolyspora spinosa for spinosad production.

Jiaxin Du, Jiale Zhang, Chen Yang, Chuanbo Zhang, Wenyu Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiaxin Du *School of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China.
Jiale Zhang *School of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China.
Chen YangSchool of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China.
Chuanbo ZhangSchool of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China. zcbtju@tju.edu.cn.
Wenyu LuSchool of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China. wenyulu@tju.edu.cn.ORCID http://orcid.org/0000-0002-4910-4025

Funding

the National Key R&D Program of China Grant No. 2021YFC2101000
6 · The paper itself

Abstract

The macrolide antibiotics spinosad, synthesized by Saccharopolyspora spinosa, is a highly effective, environmentally-friendly insecticide. However, due to poor fermentation performance and difficulties in engineering S. spinosa strains, the production cost of spinosad is still high, which restricts its industrial application. The industrial strains used for antibiotic production primarily originate from mutagenic screening, whereas traditional screening methods are time-consuming and laborious. Here, an in vitro detection method for spinosad was established to accelerate the breeding of mutated strains of S. spinosa. Firstly, a broad substrate promiscuity glycosyltransferase OleD from Streptomyces antibioticus was selected and employed for the detection of pseudoaglycone (PSA), which serves as the precursor compound for spinosad, through the utilization of colorimetric reactions coupled with glycosylation. Subsequently, the in vitro PSA detection system was optimized and applied for S. spinosa high throughput screening. The final selected mutant strain DUA15 was obtained and showed a 0.80-fold and 0.66-fold increase in spinosad and PSA production compared to the original strain, respectively. Furthermore, genetic engineering technology was combined to obtain the engineered strain D15-102, which showed a 2.9-fold increase in spinosad production compared to the original strain.

Indexed as

High-Throughput Screening AssaysMacrolidesMetabolic EngineeringSaccharopolysporaDrug CombinationsFermentationStreptomycesDrug CombinationsMacrolidesspinosadGenetic modificationHigh-throughput screeningPseudoaglyconeSaccharopolyspora spinosaSpinosad

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.